Share This Page
Drug Price Trends for NDC 00093-6031
✉ Email this page to a colleague
Average Pharmacy Cost for 00093-6031
| Drug Name | NDC | Price/Unit ($) | Unit | Date |
|---|---|---|---|---|
| RIVELSA TABLET | 00093-6031-91 | 1.28029 | EACH | 2025-08-20 |
| RIVELSA TABLET | 00093-6031-82 | 1.28029 | EACH | 2025-08-20 |
| RIVELSA TABLET | 00093-6031-91 | 1.28502 | EACH | 2025-07-23 |
| >Drug Name | >NDC | >Price/Unit ($) | >Unit | >Date |
Best Wholesale Price for NDC 00093-6031
| Drug Name | Vendor | NDC | Count | Price ($) | Price/Unit ($) | Dates | Price Type |
|---|---|---|---|---|---|---|---|
| >Drug Name | >Vendor | >NDC | >Count | >Price ($) | >Price/Unit ($) | >Dates | >Price Type |
Market Analysis and Price Projections for NDC: 00093-6031
Introduction
The drug identified by NDC: 00093-6031 refers to a pharmaceutical product registered under the National Drug Code (NDC) system administered by the FDA. The NDC code is unique to each product, encompassing drug labeler, product, and package code. This analysis provides a comprehensive market overview, current pricing landscape, and forward-looking price projections. Focused on integrating recent market trends, regulatory shifts, and competitive dynamics, this report equips stakeholders with critical intelligence for strategic decision-making.
Product Overview
Based on the NDC 00093-6031, this code corresponds to a specific marketed pharmaceutical, which, according to the FDA's databases and drug labeling, is identified as [Insert Product Name with precise classification, e.g., a branded or generic medication].
The product's primary indications include [list primary therapeutic uses], with FDA-approved forms, dosages, and administration routes detailed in its labeling. Its patent or exclusivity status—where applicable—is pivotal in projecting its market lifespan and competitive environment.
Market Landscape
Therapeutic Area and Demand Dynamics
The drug operates within the [therapeutic class, e.g., oncology, neurology, infectious diseases] segment. Market demand is driven by disease prevalence, treatment breakthroughs, reimbursement policies, and unmet medical needs.
Current epidemiological data indicates that [disease/condition] affects approximately [number] individuals globally, with an increasing incidence rate that sustains demand growth.
Competitive Environment
Key competitors include both branded and generic formulations. The entry of biosimilars or generics, post-patent expiry, substantially influences market share and pricing. The presence of innovative therapies, such as biosimilars or alternative treatment modalities, affects the product's market position.
As of [latest data year], the drug maintains a [percentage] market share within its segment, buoyed by factors such as [e.g., physician preference, formulary inclusion, insurance coverage].
Regulatory and Reimbursement Factors
Coverage policies by major payers—Medicare, Medicaid, commercial insurers—significantly impact utilization and, inherently, pricing structures. Recent reforms advocating value-based pricing and utilization management further influence market dynamics.
Pricing Landscape
Current Pricing Metrics
Analysis of recent data reveals that the average wholesale price (AWP) for the product, in its most common formulation, hovers around [USD amount] per unit or per pack. The best price reported to Medicaid or other databases indicates marginal discounts, accounting for negotiated rebates and pharmacy benefit manager (PBM) arrangements.
Factors Influencing Price Fluctuations
- Patent Status: Patent exclusivity until [year] constrains generic competition, sustaining higher premiums.
- Market Penetration: High prescribing volumes bolster revenue but face competition from generics post-patent lapse.
- Reimbursement Trends: Payers increasingly favor cost-effective alternatives, leading to downward pressure on list prices.
- Manufacturing Costs: Supply chain stability and raw material prices can influence pricing strategies.
Price Projections and Trends
Short-Term Outlook (Next 1-2 Years)
In the immediate term, prices are expected to remain relatively stable due to patent protection and limited generic competition. However, upcoming patent expirations—predicted around [date]—potentially trigger significant price erosion.
Rebate and discount strategies are anticipated to intensify as payers negotiate tighter formulary controls, contributing to net price declines estimated at [approximate percentage] annually.
Long-Term Outlook (Next 3-5 Years)
Post-patent expiry, generic competitors are projected to capture [percentage] of the market share within the first [number] years, leading to an estimated [percentage] reduction in average prices, aligning with historical precedents in similar therapeutic areas.
Emerging biosimbars or novel treatment approaches could further suppress prices. Conversely, if the drug gains orphan designation or exclusive rights via new patents, pricing could stabilize or increase, particularly if used in niche populations.
Influence of Emerging Technologies and Policies
- Biosimilar Incorporation: Expected to reduce prices by [percentage] due to competition.
- Regulatory Changes: Policies favoring biosimilar substitution could accelerate price declines.
- Reimbursement Shifts: Value-based contracts may incentivize tiered or outcome-based pricing, impacting net revenue.
Strategic Implications for Stakeholders
- Manufacturers: Should prepare for patent cliffs by diversifying product portfolios and engaging in biologics or next-generation formulations.
- Payers and PBMs: Emphasize formulary management and negotiation strategies to secure favorable rebates.
- Investors and Analysts: Monitor patent expiration timelines and regulatory developments as critical inflection points for pricing pressures.
Key Takeaways
- The current price landscape for NDC: 00093-6031 is buoyed by patent exclusivity, with prices averaging around [USD amounts].
- Patent expiry anticipated around [year] will likely catalyze a significant price reduction due to generic and biosimilar competition.
- The market demand remains robust due to high disease prevalence, but payer strategies could temper growth.
- Long-term price projections forecast declines of [percentage] over five years, contingent on patent landscape and competitive innovations.
- Stakeholders must adapt dynamically to evolving regulatory, competitive, and technological factors to optimize economic outcomes.
FAQs
1. When is patent expiration expected for NDC: 00093-6031?
The patent protecting this drug is anticipated to expire in [specific year], after which generic competitors are expected to enter the market.
2. How will the entry of biosimilars affect this product’s pricing?
The introduction of biosimilars is projected to reduce API and related product prices by [estimated percentage], leading to increased competition and downward price pressure.
3. What are the primary drivers influencing the drug's market share?
Factors include clinical efficacy, reimbursement policies, formulary inclusion, physician prescribing habits, and the availability of alternative therapies.
4. Are there regulatory incentives that could extend this drug’s market exclusivity?
Yes. Orphan drug designation or new formulation approvals can extend exclusivity, potentially maintaining higher prices longer.
5. How should manufacturers prepare for impending price declines?
Investment in pipeline development, exploring value-added formulations, and engaging with payers for favorable access agreements are essential strategies.
References
- FDA NDC Directory. [URL]
- IQVIA. (2022). Market Data and Trend Reports.
- CMS. (2022). Medicare Part B Drug Pricing and Reimbursement Policies.
- Pharma Intelligence. (2022). Industry Reports on Biosimilars and Generics.
- [Additional sources relevant to therapeutic market dynamics].
Note: The above analysis utilizes estimated data points for illustration. Precise pricing and market figures should be sourced from current databases, regulatory filings, and industry reports for accurate forecasting.
More… ↓
